JPMorgan downgraded DexCom (NASDAQ: DXCM) from Overweight to Neutral with a price target of $71.00 (from $93.00).Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE